Giving one dose of the COVID-19 vaccines currently approved in the United States could curtail the spread of the SARS-CoV-19 in the community more quickly than the recommended two doses, say two vaccine experts at the University of Washington School of Medicine. In an editorial published in the Annals of Internal Medicine, Dr. Ruanne Barnabas, associate...
Fluoride to the Rescue?
Scientists have long been aware of the dangerous overuse of antibiotics and the increasing number of antibiotic-resistant microbes that have resulted. While over-prescription of antibiotics for medicinal use has unsettling implications for human health, so too does the increasing presence of antibiotics in the natural environment. The latter may stem from the improper disposal of...
Turning microbiome research into a force for health
The microbiome comprises trillions of microorganisms living on and inside each of us. Historically, some researchers have guessed at its role in human health, but in the last decade or so genetic sequencing techniques have illuminated this galaxy of microorganisms enough to study it in detail. As researchers unravel the complex interplay between our bodies and microbiomes, they are...
Study resolves long-running controversy over critical step in gene silencing
MASSACHUSETTS GENERAL HOSPITAL BOSTON – A long-running debate over how an important gene-silencing protein identifies its targets has been resolved by researchers at Massachusetts General Hospital (MGH). Their findings, reported in Nature Structural and Molecular Biology, also explain certain mysteries about the behavior of this protein, known as Polycomb repressive complex 2 (PRC2). PRC2 helps regulate whether genes...
Mid-term clinical trial results show similar outcomes in promising cell therapies for CLI
ALPHAMED PRESS IMAGE: THE TWO THERAPIES DEMONSTRATED SIMILAR MID-TERM SAFETY AND EFFICACY, WHILE EACH CELL THERAPY HAD ITS UNIQUE ADVANTAGES AND ARE RECOMMENDED FOR CERTAIN CONDITIONS: FOR EXAMPLE, PBMNCS FOR PATIENTS WITH 2 OR MORE CRITICAL ISCHEMIC LIMBS AND PCC’S FOR PATIENTS WITH SIGNIFICANT PAIN. CREDIT: ALPHAMED PRESS Durham, NC – Mid-term results of the...
University of Miami leads groundbreaking trial for COVID-19 treatment
UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE IMAGE: CAMILLO RICORDI, M.D., DIRECTOR OF THE DIABETES RESEARCH INSTITUTE (DRI) AND CELL TRANSPLANT CENTER AT THE UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE CREDIT: UNIVERSITY OF MIAMI HEALTH SYSTEM University of Miami Miller School of Medicine researchers led a unique and groundbreaking randomized controlled trial showing umbilical cord derived...
Researchers uncover a potential treatment for an aggressive form of lung cancer
UT SOUTHWESTERN MEDICAL CENTER IMAGE: THE IMAGE DEPICTS A NON-SMALL CELL LUNG CANCER TUMOR SURROUNDED BY METABOLITES INVOLVED IN THE HEXOSAMINE BIOSYNTHESIS PATHWAY. CREDIT: CREDIT: ELIZABETH LIEU DALLAS – Jan. 5, 2021 – Researchers at the Children’s Medical Center Research Institute at UT Southwestern (CRI) have discovered a new metabolic vulnerability in a highly aggressive form of non-small cell lung cancer...
New clues why gold standard treatment for bipolar disorder doesn’t work for majority of patients
SALK INSTITUTE IMAGE: CAPTION: FROM LEFT: IPSC-DERIVED DENTATE GYRUS (DG)-LIKE NEURONS (GREEN) FROM CONTROL SUBJECT; BIPOLAR LITHIUM RESPONDER; AND BIPOLAR LITHIUM NONRESPONDER. WHILE THE PERCENTAGE OF DG-LIKE NEURONS IS THE SAME FOR CONTROL AND BIPOLAR,THE GENE ACTIVATION PROFILES ARE DIFFERENT AND THE NONRESPONDER HAS LOW LEVELS OF LEF1. CREDIT: SALK INSTITUTE LA JOLLA–(January 5, 2021)...
Viewing upper gastrointestinal cancers in a new light
TOKYO MEDICAL AND DENTAL UNIVERSITY IMAGE: LEFT. THE SPECTRAL CHARACTERISTICS OF WHITE FLUORESCENCE EXCITED BY A LASER FOR WHITE LIGHT AND THE SHORT-WAVELENGTH LASER. LCI EXPANDS AND REDUCES COLOR INFORMATION SIMULTANEOUSLY TO INTENSIFY SHADES OF RED AND WHITE.RIGHT.LCI ENHANCES THE CONTRAST OF RED AND WHITE COLOURS COMPARED WITH A WHITE LIGHT IMAGE. CREDIT: DEPARTMENT OF...
New COVID-19 RNA test gives accurate results within minutes
by University of Birmingham Credit: Unsplash/CC0 Public Domain University of Birmingham researchers have invented a COVID-19 test that reduces testing time from 30 minutes to under five, and delivers accurate results. The method is described in a preprint paper (yet to be peer-reviewed) published on MedRxiv, where the researchers also demonstrate the rapidity and sensitivity of their method using patient...